CANADIAN SOCIETY FOR NEUROTOXINS IN PAIN  
 
 

CSNP ANNUAL CONFERENCE 2012

 

Botulinum Toxin A – Then & Now
Friday, December 14th, 2012 --  8:00am to 4:00pm
 Westin Prince Hotel, 900 York Mills Road, Toronto, Ontario

 

Botulinum Toxin A is approved by Health Canada for several indications, including Cervical Dystonia, Spasticity, Overactive Bladder, Strabismus, Hyperhydrosis, Hyperfunctional facial lines, Equinous foot deformity, Hemifacial spasm and Chronic Migraine.  Although the list of approved indications continues to grow, clinicians continue to utilize toxins for off label uses. 

Since its introduction into Canada in 1990 for strabismus, the clinical utility of Botulinum Toxin A has grown geometrically. With more than 160 on and off-label uses, its unique therapeutic properties continue to make it an asset in many areas of clinical practice.

The Canadian Society for Neurotoxins in Pain (CSNP) is pleased to invite you to a one day CME event that will explore the evolution of both on-label and off-label treatment paradigms in a number of difficult to manage conditions.

Topics will include the use of toxins in:

  • Chronic Migraine and other headache disorders
  • Neuropathic pain syndromes
  • Temporomandibular Joint Disease (TMJD)
  • Overactive Bladder (OAB)
  • Myofascial pain and Osteoarthritis
  • Cosmetic techniques for therapeutic injectors
  • Targeted Toxins in Pain

Faculty:

  • Dr. Andrew Blumenfeld, Neurologist, Headache Center of Southern California, USA
  • Dr. Brian Freund, Oral & Maxillofacial Surgeon, Crown Institute
  • Dr. Allan Gordon, Neurologist, Wasser Pain Clinic, University of Toronto
  • Dr. Pankaj Dhawan, Physiatrist, University of British Columbia
  • Dr. Sendor Herschorn, Urologist, University of Toronto
  • Dr. Ian Finkelstein, GP interventional pain, Toronto Headache & Pain Clinic
  • Dr. Kevin Smith, Dermatologist, Niagara Falls Dermatology & Skin Care Centre
  • Dr. Gordon Ko, Physiatrist, Can. Centre Integrative Medicine, University of Toronto

Educational Objectives:

  • Attendees will gain an understanding of the pharmacologic and physiologic interactions that make Botulinum toxin A effective in different clinical conditions
  • Attendees will be made aware of the literature that supports the use of toxins in different clinical situations.
  • Attendees will learn how to select cases suitable for toxin therapy.
  • Attendees will gain knowledge of the newest techniques to maximize patient response.

This event has been accredited by the RCPSC and CFPC for up to 6.5 credit hours

*** RSVP to Kathy Woodgate at kathy@tasteculinary.ca  or by fax 416.483.9695 or phone 416.569.2058 ***

REGISTRATION FEE -- $99.00 (increases to $199 after Nov. 30th)

 


 
 


AGENDA

Speaker Presentations

Chronic Migraine

Neuropathic Pain

Temporomandibular Disorders

Overactive Bladder

Myofascial Pain

Aesthetic Considerations

 

 


BACK